These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7135457)

  • 1. Plasma disopyramide concentrations following a 300-mg oral loading dose in acute myocardial infarction.
    Weissberg PL; Matenga J; Hayler AM; Holt DW
    Ther Drug Monit; 1982; 4(3):277-80. PubMed ID: 7135457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disopyramide kinetics in patients with acute myocardial infarction.
    Ilett KF; Madsen BW; Woods JD
    Clin Pharmacol Ther; 1979 Jul; 26(1):1-7. PubMed ID: 445953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged variability in plasma protein binding of disopyramide after acute myocardial infarction.
    David BM; Ilett KF; Whitford EG; Stenhouse NS
    Br J Clin Pharmacol; 1983 Apr; 15(4):435-41. PubMed ID: 6849779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disopyramide plasma levels in cardiac patients on maintenance therapy.
    Landmark K; Storstein L; Larsen A
    Acta Med Scand; 1979; 206(5):385-9. PubMed ID: 525439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of disopyramide following myocardial infarction with special reference to oral and intravenous dose regimens.
    Ward JW; Kinghorn GR
    J Int Med Res; 1976; 4(1 Suppl):49-53. PubMed ID: 1026529
    [No Abstract]   [Full Text] [Related]  

  • 6. Conversion from intravenous to oral slow-release disopyramide in acute myocardial infarction.
    Zannad F; Royer-Morrot MJ; Zakari I; Sadoul N; Royer RJ
    Fundam Clin Pharmacol; 1987; 1(3):219-24. PubMed ID: 3428841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A placebo-controlled study to determine the efficacy of oral disopyramide phosphate for the prophylaxis of ventricular dysrhythmias after acute myocardial infarction.
    Kumana CR; Rambihar VS; Tanser PH; Cairns JA; Gupta RN; Wildeman RA; Johnston M; Johnson AL; Gent M
    Br J Clin Pharmacol; 1982 Oct; 14(4):519-27. PubMed ID: 6753887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained release disopyramide compared to plain capsules after change-over from intravenous infusion.
    Lien E; Bakke OM
    Br J Clin Pharmacol; 1983 Jul; 16(1):71-6. PubMed ID: 6882625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disopyramide in acute myocardial infarction: problems with changing pharmacokinetics.
    Elliott HL; Thomson AH; Bryson SM
    Eur J Clin Pharmacol; 1986; 30(3):345-7. PubMed ID: 3732373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute oral antiarrhythmic testing with disopyramide.
    García-Barreto D; Toruncha A; Gonzalez-Gomez A; Llerena L; Groning E; Hernandez-Cañero A
    Clin Cardiol; 1981; 4(6):330-5. PubMed ID: 7326884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral disopyramide after admission to hospital with suspected acute myocardial infarction. U. K. Rythmodan Multicentre Study Group.
    Postgrad Med J; 1984 Feb; 60(700):98-107. PubMed ID: 6369290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disopyramide pharmacokinetics in patients with acute myocardial infarction.
    Pentikäinen PJ; Huikuri H; Jounela AJ; Wilen G
    Eur J Clin Pharmacol; 1985; 28(1):45-51. PubMed ID: 3987785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of disopyramide after administration of conventional capsules and sustained-release tablets.
    Nauta IL; van de Calseyde J; Hertzberger DP
    Curr Med Res Opin; 1983; 8(8):582-93. PubMed ID: 6653136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous and oral disopyramide after myocardial infarction.
    Nicholls DP; Haybyrne T; Barnes PC
    Lancet; 1980 Nov; 2(8201):936-8. PubMed ID: 6107587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative haemodynamic effects of intravenous lignocaine, disopyramide and flecainide in uncomplicated acute myocardial infarction.
    Silke B; Frais MA; Verma SP; Reynolds GW; Hafizullah M; Kalra PA; Jackson NC; Taylor SH
    Br J Clin Pharmacol; 1986 Dec; 22(6):707-14. PubMed ID: 3105568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous disopyramide in myocardial infarction: a haemodynamic study.
    Marrott PK; Nairn PL; Hill PD; Turner G; Sharman J
    N Z Med J; 1983 Jan; 96(723):4-7. PubMed ID: 6571755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction.
    Wilcox RG; Rowley JM; Hampton JR; Mitchell JR; Roland JM; Banks DC
    Lancet; 1980 Oct; 2(8198):765-9. PubMed ID: 6107452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction.
    Jennings G; Jones MS; Besterman EM; Model DG; Turner PP; Kidner PH
    Lancet; 1976 Jan; 1(7950):51-4. PubMed ID: 54578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards.
    Zainal N; Carmichael DJ; Griffiths JW; Besterman EM; Kidner PH; Gillham AD; Summers GD
    Lancet; 1977 Oct; 2(8044):887-9. PubMed ID: 72237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral disopyramide dosage regimes in ischaemic heart disease.
    Bryson SM; Fotheringham GH; Struthers MG; Whiting B
    J Clin Hosp Pharm; 1982 Mar; 7(1):37-42. PubMed ID: 7096577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.